Gaudium IVF and Women Health Limited has issued a clarification to stock exchanges regarding recent share price movements, confirming that the volatility is purely market driven with no undisclosed material information pending. The company responded to specific queries from both BSE and NSE on April 16, 2026, addressing concerns about significant price fluctuations in its scrip.

Regulatory Compliance and Disclosure

The gaudium ivf & women health management emphasized its commitment to regulatory compliance, stating that all material events and information affecting company operations and performance have been disclosed to stock exchanges within stipulated timeframes. The company confirmed adherence to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring transparency in all material disclosures.

Exchange Communications

The clarification was issued in response to formal communications from both major stock exchanges:

Company Position on Price Movement

The company categorically stated that there is no undisclosed price sensitive information or impending announcements that could influence share price or volume behavior. Management attributed the recent price movements entirely to market forces, dismissing speculation about any underlying corporate developments or material events that have not been publicly disclosed.

Future Disclosure Commitments

Gaudium IVF and Women Health Limited reaffirmed its commitment to maintaining transparency with stakeholders and regulatory bodies. The company assured continued prompt disclosure of all material events, information, and corporate actions as required under SEBI regulations. This commitment underscores the company's dedication to maintaining investor confidence through transparent communication practices.

The clarification was signed by Company Secretary and Compliance Officer Naveen Kumar, emphasizing the formal nature of the response and the company's commitment to regulatory compliance in addressing market concerns about share price volatility.

Gaudium IVF & Women Health Limited has announced a significant corporate milestone with the formal update of its Corporate Identification Number following its recent stock exchange listing. The company communicated this development to both major Indian stock exchanges on April 15, 2026.

Corporate Identification Number Update

The company's CIN has been officially changed from 'U85100DL2015PLC278296' to 'L85100DL2015PLC278296', reflecting its transition from unlisted to listed status. This change occurred pursuant to the listing of the company's equity shares on both the National Stock Exchange of India Limited and BSE Limited.

Company Profile and Financial Structure

Gaudium IVF and Women Health Limited, formerly known as Gaudium IVF and Women Health Private Limited, was incorporated on March 24, 2015. The company operates under the jurisdiction of ROC Delhi II and maintains its registered address at B1/51, Janak Puri, Janakpuri B-1, West Delhi, New Delhi.

The company maintains active compliance status and held its last Annual General Meeting on September 27, 2025. Its balance sheet date is March 31, 2025.

Leadership and Governance Structure

The company's board comprises both promoter and independent directors, ensuring balanced corporate governance. The promoter directors include Manika Khanna as Managing Director and Peeyush Khanna as Whole-time Director, both appointed since the company's incorporation.

The independent directors include Rajesh Chunilal Bhojani, Suresh Marpu, and Brajesh Singh Bhadauria. The company's key management personnel include Naveen Kumar as Company Secretary and Compliance Officer, and Rakesh Kumar Sharma as Chief Financial Officer.

Banking Relationships and Charges

The company maintains banking relationships with major financial institutions. The Ministry of Corporate Affairs records show charges with ICICI Bank Limited for ₹27,99,70,000 that was satisfied on October 9, 2025, and an ongoing charge with HDFC Bank Limited for ₹7,50,00,000 created on November 16, 2024.

This CIN update represents a formal recognition of the company's successful transition to public listing status, marking an important milestone in its corporate journey from a private limited company to a publicly listed entity on India's premier stock exchanges.